By Josée Rose
Biote said Chief Executive Officer Terry Weber is expected to retire effective Feb. 1, and would be succeeded by Bret Christensen.
The hormone- and therapeutic-health and wellness company said Weber will advise the company's board of directors.
Christensen has over two decades of leadership experience in the healthcare industry, Biote said, and has worked at Hologic, Myriad Genetics and Insulet.
Write to Josée Rose at josee.rose@wsj.com
(END) Dow Jones Newswires
January 30, 2025 16:47 ET (21:47 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.